Dorman Products vs Gentherm
Add, change or remove companies; up to four.
KIRA’s take AI analyst
I put Dorman Products and Gentherm side by side, using each one’s latest annual report. Here is what stands out:
- Dorman Products is the larger business, with $2.1B of revenue in fiscal 2025 against $1.5B for Gentherm.
- Dorman Products grew revenue faster (6.0%, against 2.9%).
- Dorman Products kept more of each dollar of sales as operating profit (14.1% operating margin, against 5.5%).
- Gentherm turned more of its sales into free cash flow (4.1% FCF margin, against 3.6%).
- Dorman Products earned a higher return on the capital invested in it (12.4%, against 5.8%).
- Investors pay more for each dollar of Gentherm’s earnings: a P/E of 109.7x against 17.2x for Dorman Products.
Who comes out ahead
Of the 11 measures where higher (or lower) is clearly better, how many each company leads.
Dorman Products
DORM
8/11
Revenue growth5-year growthGross marginOperating marginNet marginReturn on capitalReturn on equityPiotroski F-score
Gentherm
THRM
3/11
FCF marginNet debt / EBITDAShare count change
Side by side
Best in the row
| Latest fiscal year | DORM FY25 | THRM FY25 |
|---|---|---|
| Size | ||
| Market cap | $3.7B | $977M |
| Revenue | $2.1B | $1.5B |
| Free cash flow | $75.7M | $61.1M |
| Net income | $204M | $18.3M |
| Growth | ||
| Revenue growth | 6.0% | 2.9% |
| 5-year growth | 14.3% | 10.4% |
| Share count change | −0.7% | −1.7% |
| Profitability | ||
| Gross margin | 42.1% | 24.2% |
| Operating margin | 14.1% | 5.5% |
| Net margin | 9.6% | 1.2% |
| FCF margin | 3.6% | 4.1% |
| Return on capital | 12.4% | 5.8% |
| Return on equity | 14.7% | 2.7% |
| Balance sheet | ||
| Net debt | $391M | $28.3M |
| Net debt / EBITDA | 1.2x | 0.2x |
| Dividends and buybacks | $0.0M | $10.0M |
| Valuation & quality | ||
| P/E | 17.2x | 109.7x |
| Piotroski F-score | 8 | 6 |
Ten years
Revenue
Operating margin
Free cash flow
Return on capital
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.